Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Gingipains from Porphyromonas gingivalis increase the chemotactic and respiratory burst-priming properties of the 77-amino-acid interleukin-8 variant.

Dias IH, Marshall L, Lambert PA, Chapple IL, Matthews JB, Griffiths HR.

Infect Immun. 2008 Jan;76(1):317-23. Epub 2007 Nov 19.

3.

The role of phagocytosis, oxidative burst and neutrophil extracellular traps in the interaction between neutrophils and the periodontal pathogen Porphyromonas gingivalis.

Jayaprakash K, Demirel I, Khalaf H, Bengtsson T.

Mol Oral Microbiol. 2015 Oct;30(5):361-75. doi: 10.1111/omi.12099. Epub 2015 May 4.

PMID:
25869817
4.
5.

Cysteine proteases from Porphyromonas gingivalis and TLR ligands synergistically induce the synthesis of the cytokine IL-8 in human artery endothelial cells.

Deng S, Jepsen S, Dommisch H, Stiesch M, Fickenscher H, Maser E, Chen H, Eberhard J.

Arch Oral Biol. 2011 Dec;56(12):1583-91. doi: 10.1016/j.archoralbio.2011.06.018. Epub 2011 Jul 30.

PMID:
21802653
6.

Gingipains from Porphyromonas gingivalis synergistically induce the production of proinflammatory cytokines through protease-activated receptors with Toll-like receptor and NOD1/2 ligands in human monocytic cells.

Uehara A, Imamura T, Potempa J, Travis J, Takada H.

Cell Microbiol. 2008 May;10(5):1181-9. doi: 10.1111/j.1462-5822.2008.01119.x. Epub 2008 Jan 7.

PMID:
18182086
7.

A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice.

Genco CA, Odusanya BM, Potempa J, Mikolajczyk-Pawlinska J, Travis J.

Infect Immun. 1998 Sep;66(9):4108-14.

8.

Porphyromonas gingivalis regulates TREM-1 in human polymorphonuclear neutrophils via its gingipains.

Bostanci N, Thurnheer T, Aduse-Opoku J, Curtis MA, Zinkernagel AS, Belibasakis GN.

PLoS One. 2013 Oct 4;8(10):e75784. doi: 10.1371/journal.pone.0075784. eCollection 2013.

9.
10.

Dual regulation of interleukin-8 production in human oral epithelial cells upon stimulation with gingipains from Porphyromonas gingivalis.

Uehara A, Naito M, Imamura T, Potempa J, Travis J, Nakayama K, Takada H.

J Med Microbiol. 2008 Apr;57(Pt 4):500-7. doi: 10.1099/jmm.0.47679-0.

PMID:
18349372
11.

Gingipains inactivate a cell surface ligand on Porphyromonas gingivalis that induces TLR2-and TLR4-independent signaling.

Kishimoto M, Yoshimura A, Naito M, Okamoto K, Yamamoto K, Golenbock DT, Hara Y, Nakayama K.

Microbiol Immunol. 2006;50(4):315-25.

12.
13.

Degradation of vascular endothelial thrombomodulin by arginine- and lysine-specific cysteine proteases from Porphyromonas gingivalis.

Inomata M, Ishihara Y, Matsuyama T, Imamura T, Maruyama I, Noguchi T, Matsushita K.

J Periodontol. 2009 Sep;80(9):1511-7. doi: 10.1902/jop.2009.090114.

PMID:
19722803
15.

Neutrophils alter epithelial response to Porphyromonas gingivalis in a gingival crevice model.

Bondy-Carey JL, Galicia J, Bagaitkar J, Potempa JS, Potempa B, Kinane DF, Veillard F, Scott DA.

Mol Oral Microbiol. 2013 Apr;28(2):102-13. doi: 10.1111/omi.12008. Epub 2012 Nov 22.

16.

Effect of inactivation of the Arg- and/or Lys-gingipain gene on selected virulence and physiological properties of Porphyromonas gingivalis.

Grenier D, Roy S, Chandad F, Plamondon P, Yoshioka M, Nakayama K, Mayrand D.

Infect Immun. 2003 Aug;71(8):4742-8.

17.

Role of gingipains in growth of Porphyromonas gingivalis in the presence of human serum albumin.

Grenier D, Imbeault S, Plamondon P, Grenier G, Nakayama K, Mayrand D.

Infect Immun. 2001 Aug;69(8):5166-72.

18.

Role of gingipains R in the pathogenesis of Porphyromonas gingivalis-mediated periodontal disease.

Genco CA, Potempa J, Mikolajczyk-Pawlinska J, Travis J.

Clin Infect Dis. 1999 Mar;28(3):456-65. Review.

PMID:
10194062
19.

Porphyromonas gingivalis proteinases as virulence factors in the development of periodontitis.

Travis J, Pike R, Imamura T, Potempa J.

J Periodontal Res. 1997 Jan;32(1 Pt 2):120-5. Review.

PMID:
9085221
20.

Gingipains as candidate antigens for Porphyromonas gingivalis vaccine.

Nakagawa T, Saito A, Hosaka Y, Ishihara K.

Keio J Med. 2003 Sep;52(3):158-62. Review.

Supplemental Content

Support Center